Skip to content

Clinical trials

Phase 2 Atherosclerosis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Phase: Phase 2 Country / region: United Kingdom Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20091
20102
20111
20121
20132
20161
20171
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Novartis Pharmaceuticals2
AdvanceCor GmbH1
AstraZeneca1
Cambridge University Hospitals NHS Foundation Trust1
Eli Lilly and Company1
Genzyme, a Sanofi Company1
Imperial College London1
OrbusNeich1
Silence Therapeutics plc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis14
Cardiovascular Diseases2
Coronary Artery Disease2
Diabetes Mellitus2
Dyslipidemias2
Hyperlipoproteinemia Type II2
Acute Coronary Syndrome1
Amaurosis Fugax1
Carotid Stenosis1
Coronary Disease1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.